Labcorp Holdings operates one of the largest clinical laboratory testing networks in the United States, performing diagnostic blood tests, genetic tests and other laboratory analyses ordered by physicians for patients, along with a drug development services business supporting pharmaceutical research. Its laboratory network processes an enormous volume of routine and specialized diagnostic tests daily, giving it significant scale advantages in testing efficiency and turnaround time compared to smaller regional or hospital-based labs. Labcorp's drug development business provides clinical trial and related research services to pharmaceutical companies, giving the company a second major business line beyond its core diagnostic testing operations. The company's revenue is tied to overall healthcare utilization and diagnostic testing volumes, which tend to be relatively stable and non-discretionary, along with pharmaceutical industry research spending that drives demand for its drug development services.